• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Board Meeting, 07-11-2025: Outcome of Board Meeting

    07-11-2025 | 05:38 pm

    AstraZeneca Pharma's board approved Q2 FY26 financial results: Revenue ₹55.9 Cr (Qtr), ₹1085.4 Cr (H1). PAT ₹54.22 Cr (Qtr), ₹110.05 Cr (H1). The company is selling its manufacturing site assets after operations ceased.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited